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Abstract
Background
Cancer awareness campaigns aim to increase awareness of the potential seriousness of
signs and symptoms of cancer, and encourage their timely presentation to healthcare ser-
vices. Enhanced understanding of the prevalence of symptoms possibly indicative of cancer
in different population subgroups, and associated general practitioner (GP) help-seeking
behaviour, will help to target cancer awareness campaigns more effectively.
Aim
To determine: i) the prevalence of 21 symptoms possibly indicative of breast, colorectal,
lung or upper gastrointestinal cancer in the United Kingdom (UK), including six ‘red flag’
symptoms; ii) whether the prevalence varies among population subgroups; iii) the proportion
of symptoms self-reported as presented to GPs; iv) whether GP help-seeking behaviour var-
ies within population subgroups.
Methods
Self-completed questionnaire about experience of, and response to, 25 symptoms (includ-
ing 21 possibly indicative of the four cancers of interest) in the previous month and year;
sent to 50,000 adults aged 50 years or more and registered with 21 general practices in Staf-
fordshire, England or across Scotland.
Results
Completed questionnaires were received from 16,778 respondents (corrected response
rate 34.2%). Almost half (45.8%) of respondents had experienced at least one symptom
possibly indicative of cancer in the last month, and 58.5% in the last year. The prevalence of
individual symptoms varied widely (e.g. in the last year between near zero% (vomiting up
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blood) and 15.0% (tired all the time). Red flag symptoms were uncommon. Female gender,
inability to work because of illness, smoking, a history of a specified medical diagnosis, low
social support and lower household income were consistently associated with experiencing
at least one symptom possibly indicative of cancer in both the last month and year. The pro-
portion of people who had contacted their GP about a symptom experienced in the last
month varied between 8.1% (persistent cough) and 39.9% (unexplained weight loss); in the
last year between 32.8% (hoarseness) and 85.4% (lump in breast). Nearly half of respon-
dents experiencing at least one red flag symptom in the last year did not contact their GP
about it. Females, those aged 80+ years, those unable to work because of illness, ex-smok-
ers and those previously diagnosed with a specified condition were more likely to report a
symptom possibly indicative of cancer to their GP; and those on high household income less
likely.
Conclusion
Symptoms possibly indicative of cancer are common among adults aged 50+ years in the
UK, although they are not evenly distributed. Help-seeking responses to different symptoms
also vary. Our results suggest important opportunities to provide more nuanced messaging
and targeting of symptom-based cancer awareness campaigns.
Introduction
Although there has been important progress in recent years, the United Kingdom (UK) con-
tinues to have poorer cancer survival rates than similarly developed countries in Europe and
beyond [1]. Current national cancer strategies in England [2] and Scotland [3] include cancer
awareness campaigns as part of a range of actions aimed at closing this survival gap. Cancer
awareness campaigns seek to increase the public’s awareness of the link between certain signs
and symptoms and cancer, and encourage their prompt presentation to healthcare services.
The need for such initiatives is indicated partly by evidence that many people in the UK rarely
consider their symptoms to be a possible indicator of cancer [4], even in high risk groups such
as smokers [5–8]. Indeed there may be a general lack of awareness of cancer symptoms among
the UK population [9–12].
Effective targeting of cancer awareness campaigns requires contemporaneous information
about the prevalence and distribution of cancer-related symptoms within the general popula-
tion, and associated patterns of help-seeking behaviour- in the UK particularly general practi-
tioner (GP) contact. Studies from Denmark show that cancer-related symptoms are common
in the general population. A cross-sectional study conducted in 2007 of 13,777 adults older
than 19 years and living in Funen, Denmark, reported that 15% of participants had at least one
of four common cancer red flag symptoms (also known as alarm symptoms) in the preceding
12 months [13]. A larger, predominantly internet-based survey undertaken in 2012 of 49,706
adults older than 19 years and residing across Denmark, found that 90% experienced in the
preceding four weeks at least one of 44 symptoms, including red flag symptoms of lung, gas-
tro-intestinal, gynaecological and urogenital cancer; mean number of any symptom 5.4 (Stan-
dard Deviation, SD not given) [14].
In the UK, a pooled analysis of two primary-care based surveys involving 3,756 adults older
than 49 years found that 46% of respondents had experienced at least one of 10 cancer red flag
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symptoms in the previous three months; mean number of symptoms 1.73 (SD 1.17) [15].
Overall, a third of people with symptoms had not contacted their GP about them, with the pro-
portion seeking help varying by symptom experienced and characteristics of respondents.
These findings suggest important opportunities for the targeting of cancer awareness cam-
paigns. Key limitations of these UK studies, however, include the use of symptoms from the
Cancer Awareness Measure [16] rather than those specific to cancer site (e.g. rectal bleeding
for colorectal cancer or lump in breast for breast cancer), the small sample size and the rela-
tively small number of respondent characteristics assessed. Another UK general population
study of the prevalence of 25 physical and psychological symptoms in working-age adults pro-
vided limited information about cancer-related symptoms [17, 18].
The Understanding Symptom Experiences Fully (USEFUL) study aims to improve under-
standing of the prevalence, patterning and response to symptoms associated with breast, colo-
rectal, lung and upper gastrointestinal cancer in older adults living in the UK general
population. We report here its findings in relation to the experienced prevalence of symptoms
possibly indicative of these four cancers, the characteristics of people experiencing those symp-
toms, the levels of self-reported GP help-seeking and the characteristics of those taking this
action.
Methods
Ethics statement
National Research Ethics Service Committee East Midlands- Derby (REC reference 14/EM/
1124. IRAS Project ID 160441) confirmed its favourable ethical opinion of the study, and each
relevant National Health Service authority gave Research and Development management
approval before the survey began. All participants received written information about the
study; participants were deemed to have been given consent to participate by returning a com-
pleted questionnaire.
Study design
The USEFUL study was underpinned by theoretical models developed to understand response
to symptoms. The Model of Pathways to Treatment [19] provided a framework for distin-
guishing key events in the cancer diagnostic pathway. A framework integrating understanding
from three process models of response to symptoms, the Commonsense Self-Regulation
Model (CSM) [20], the Illness Action Model [21] and the Network Episode Model [22] guided
investigation of the way in which symptoms and responses to them are interpreted and evalu-
ated by people experiencing them.
The first phase of the USEFUL study involved surveying a large community-based sample
of adults aged 50 years or more. This age group was chosen because of its higher risk of cancer
and its frequent focus for cancer prevention interventions such as screening programmes or
cancer awareness campaigns.
Questionnaire development
A questionnaire for self-completion was developed to explore symptoms possibly indicative of
breast, colorectal, lung and upper gastrointestinal cancer. Breast, colorectal and lung cancer
were chosen as these are amongst the four most common cancers in the UK; all usually present
symptomatically. Upper gastrointestinal cancer was included because it is a relatively common
cancer often associated with non-specific symptoms and long diagnostic intervals. All of the
chosen cancers have been the subject of cancer awareness campaigns conducted in the UK.
Epidemiology of symptoms possibly indicative of cancer
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The choice of symptoms for inclusion in the questionnaire was guided by a review of academic
literature and current clinical guidelines, and discussion with academic and clinical colleagues.
The wording of each selected symptom was guided by academic literature, academic clinicians
and, crucially, lay members of the University of Aberdeen College of Life Sciences and Medi-
cine Patient Engagement Group, who provided key input into questionnaire format and word-
ing, particularly whether the symptom descriptors captured lay understanding of each
symptom. Five of the chosen symptoms included the word ‘persistent’ in an attempt to differ-
entiate between symptoms that clinicians or campaigns may consider more serious and more
likely to be indicative of cancer rather than a self-limiting illness. The final questionnaire
included two symptoms possibly indicative of breast cancer, four of colorectal cancer, seven of
lung cancer and five of upper gastrointestinal cancer (Table 1). Six symptoms (difficulty swal-
lowing, unexplained weight loss, coughing up blood, blood in stool or rectal bleeding, vomiting up
blood, lump in breast were red flag symptoms (alarm or warning symptoms and/or signs that
suggest a potentially serious underlying disease.) These red flag symptoms were based on those
highlighted in cancer referral guidelines. The questionnaire also asked about three ‘non-spe-
cific’ symptoms possibly indicative of cancer at any site; and four more general, ‘masking’,
symptoms less likely to be indicative of cancer (to help conceal the focus of the questionnaire).
In a further attempt to avoid biasing responses we broke up the ordering of symptoms. The
questionnaire was piloted in two general practices in England and Scotland, and subsequently
modified slightly before the main mailing. S1 File details the full content of the questionnaire.
Table 1. Symptom description and type included in the questionnaire, listed as presented in the questionnaire.
Headaches Masking symptom
Persistent indigestion/heartburn Upper gastrointestinal cancer associated
Difficulty swallowing !! Upper gastrointestinal cancer associated
Stomach or abdominal pain Upper gastrointestinal cancer associated
Chest pain Lung cancer associated
Hoarseness Lung cancer associated
Loss of appetite Non-specific cancer associated
Unexplained weight loss !! Non-specific cancer associated
Persistent cough Lung cancer associated
Change in ongoing cough Lung cancer associated
Persistent diarrhoea Colorectal cancer associated
Persistent constipation Colorectal cancer associated
Coughing up phlegm Lung cancer associated
Coughing up blood !! Lung cancer associated
Shortness of breath Lung cancer associated
Wheezy chest Masking symptom
Change in bladder habits Masking symptom
Change in bowel habits Colorectal cancer associated
Blood in stool or rectal bleeding !! Colorectal cancer associated
Back or joint pain Masking symptom
Persistent vomiting Upper gastrointestinal cancer associated
Vomiting up blood !! Upper gastrointestinal cancer associated
Lump in breast !! Breast cancer associated
Breast change other than lump Breast cancer associated
Tired all the time Non-specific cancer associated
!! = red flag cancer symptom
https://doi.org/10.1371/journal.pone.0228033.t001
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Data collection
Between May 2015 and January 2016, invitation letters were sent on behalf of 21 general prac-
tices (10 in Staffordshire, England and 11 across Scotland), to 50,000 adults aged 50 years or
more. The sample size was based on a desire for reasonable precision for the annual prevalence
of common symptoms (e.g. a priori point estimate for lump in breast of 3.3%, 99% confidence
interval 3.0 to 3.6, assuming a response rate of 40%).
Practices were identified by two primary care research networks asked to recruit practices
with different levels of rurality and deprivation. Coordinators from the networks ran searches
to identify eligible patients and applied pre-specified exclusion criteria (dementia, learning dis-
abilities, living in a nursing home or receiving palliative care). GPs in each practice were then
asked to check the lists for any other patients they wished to exclude. The reason for, and num-
ber of, such exclusions was not collected. In practices with fewer than 2,500 patients aged 50
+ years, all patients were identified and screened. In larger practices, a random sample of those
aged 50+ years was taken to achieve the overall required sample size.
Eligible individuals remaining after exclusions were sent a study information leaflet and
invitation to complete an online questionnaire. The invitees were told that the study’s purpose
was to enquire about symptoms experienced, their effects, participants’ thoughts about the
symptoms, and actions taken. Cancer was not mentioned, to avoid anxiety and minimise the
risk of biasing responses. Non-respondents received reminders three and six weeks after the
initial invitation letter. Reminders included a printed questionnaire to enable completion by
post if preferred. Patients were able to opt-out by a study telephone number, e-mail or return
of a blank questionnaire.
Data management
In order to maintain invitee confidentiality, study packs were dispatched by the University of
Aberdeen Data Management Team in Scotland and by the West Midlands Clinical Research
Network in England. Questionnaires (identified by participant ID only) were returned to the
research team at the Centre for Academic Primary Care, University of Aberdeen. The Data
Management Team had access to the full postcode of respondents, to assign rurality and depri-
vation score. Postcode data were removed from the main dataset before it was forwarded to
the research team for analysis. For participants from England we used the English higher level
geographies Rural-Urban Classification 2011 [23] and Index of Multiple Deprivation (IMD)
for England 2015 [24], and for those from Scotland, the Scottish Government 6-fold Urban
Rural Classification 2013/2014 [25] and Scottish Index of Multiple Deprivation (SIMD) 2012
[26].
Data analysis
After data cleaning, differences between groups with categorical data was assessed using the
Chi-squared test. The proportion of individuals overall and in different subgroups reporting
individual or combinations of symptoms possibly indicative of different cancers was calculated
using SPSS Statistics version 24 [27], and Allto consulting software [28] for surrounding 99%
confidence intervals. The chance of reporting symptoms possibly indicative of cancer, and
associated GP help-seeking, in different population subgroups was estimated using binary
logistic regression in SPSS, to calculate unadjusted and adjusted odds ratios, and their sur-
rounding 99% confidence intervals. We estimated 99% confidence intervals because of the
large number of proportions and odds ratios calculated. Variables chosen a priori for inclusion
in the adjusted model were based on previous research [17, 18]: gender, age, marital status,
social support, education, employment, household income, smoking, rurality and history of
Epidemiology of symptoms possibly indicative of cancer
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any of the medical conditions specified in the questionnaire. All of the variables were entered
simultaneously into the model To enable the entire dataset to be used in the adjustments, the
six Scottish levels and three English levels of each country’s rural-urban classification were
combined into a single nine-level categorical variable, with Scottish large urban areas as the
referent group. We used the area-based deprivation variables to examine whether response
rates were related to this characteristic. We did not, however, use them in the adjusted models
as other, individual-based, measures of socioeconomic status were available for respondents. It
should be noted that the denominator for proportions sometimes changed because of missing
values or inconsistent responses that could not be reconciled. In the analyses looking at GP
help-seeking, symptomatic people with information missing about contact with their GP were
assumed not to have seen their family doctor, and so were combined with those responding no
to questions about this action.
Results
Response
After three mailings, 16,778 completed questionnaires were returned (corrected response rate
after removing 403 deaths or de-registrations and 565 undelivered questionnaires 34.2%;
range between practices 18.1% to 45.7%). Roughly a third of all questionnaires were completed
on-line (5182, 30.9%), with a higher proportion from respondents in Scotland than England
(35.1% vs 26.2%; x2 = 155.4, p<0.001). In both Scotland and England significantly higher
response rates were achieved from women, those living in more rural areas and those in less
deprived areas (S1 Table). The response rate in England increased significantly with age from
50–54 to 70–74 years before declining in older age groups; there were no significant age differ-
ences in Scotland.
Characteristics of respondents
More than half of all respondents were female (53.8%), younger than 70 years (71.0%), mar-
ried or living with a partner (74.4%), had high social support (58.5%), had a professional,
degree or postgraduate qualification (50.6%), were retired (53.4%), had never smoked
(54.0%) and lived in an urban area (England 70.8%, Scotland 52.7%), Table 2. Most partici-
pants indicated a history of having been diagnosed with at least one of the conditions speci-
fied in the questionnaire (78.9%). The most common conditions were high blood pressure
(32.8% of all respondents), arthritis/rheumatic disorder (23.5%) and stomach/digestive dis-
orders (18.4%). Roughly a tenth of respondents (10.6%) reported having ever been diagnosed
with cancer. Nearly all respondents reported being in good (35.0%), very good (36.1%) or
excellent (11.4%) health.
Most (76.0%) respondents said that we could review their medical records, 39.4% agreed to
a telephone interview and 66.1% agreed to being contacted about future studies.
Total number of symptoms experienced
Over two thirds (69.4%) of all respondents had experienced at least one of the 25 symptoms in
the last month; 26.5% had 3 or more symptoms (Table 3). These figures were almost identical
when participants reporting a history of cancer were excluded (69.1% and 26.1% respectively).
Since this was the case, and since people diagnosed with one cancer would still be targets for
cancer awareness campaigns for other cancers, we have presented results based on replies
from all respondents. Nearly half (45.8%) of all respondents had at least one symptom possibly
indicative of the four cancers in the last month; 13.3% had 3 or more such symptoms, mean
Epidemiology of symptoms possibly indicative of cancer
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Table 2. Selected socio-demographic characteristics of respondents in the study.
Demographic group Sub-group N %
Sex Male 7745 46.2
Female 9033 53.8
Age group 50–59 5564 33.1
60–69 6350 37.9
70–79 3712 22.1
80+ 1152 6.9
Marital status Single 1114 6.8
Married/living together 12272 74.4
No longer married 3100 18.8
Social support Low 910 5.8
Medium 5572 35.4
High 9263 58.8
Educational status No educational qualifications 2050 12.6
Secondary school or equivalent 5356 32.8
College/vocational courses and other 660 4.0
Professional qualification 4250 26.1
Degree or postgraduate qualification 3996 24.5
Employment status Working full-time 3870 23.5
Working part-time 1598 9.7
Self-employed 1226 7.5
Retired 8780 53.4
Unable to work due to illness/disability 423 2.6
Others not in paid employment 552 3.4
Household income < £15,000 3561 24.0
£15,000–29,999 4523 30.5
£30,000–49,999 3650 24.6
>£50,0000 3106 20.9
Smoking status Never smoked 8872 54.0
Ex-smoker 6095 37.1
Current smoker 1471 8.9
Urban Rural Classification Scotland Large urban areas 3234 36.5
Other urban areas 1434 16.2
Accessible small towns 640 7.2
Remote small towns 1569 17.7
Accessible rural 959 10.8
Remote rural 1013 11.4
Rural Urban Classification England Urban with city and town 2367 30.1
Urban with significant rural 3201 40.7
Largely rural 2293 29.2
Diagnosis of specified condition † No 3534 21.1
Yes 13244 78.9
† ever been diagnosed with asthma, cancer, epilepsy, chronic bronchitis/COPD, other chest disorder, heart disorder,
stroke, diabetes, high blood pressure, liver disorder, arthritis/rheumatic disorder, mental health disorder, thyroid
disorder, stomach/digestive disorder, other condition (to be specified).
https://doi.org/10.1371/journal.pone.0228033.t002
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number 1.01 (SD 1.57) (Table 3). Symptom prevalence was slightly higher when the time
frame of last year was used; 80.0% of all respondents experienced at least one of the 25 symp-
toms and 58.5% at least one symptom possibly indicative of the four cancers (mean number
1.51, SD 1.96).
Individual symptoms experienced
There was a wide range in the reported prevalence of individual symptoms possibly indicative
of cancer; for example, in the last month between near zero (vomiting up blood) and 15.0%
(tired all the time) (Table 4). Red flag symptoms were at the lower end of the prevalence range.
Even so, 7.4% of respondents reported experiencing at least one of the six red flag symptoms
in the last month, and 12.7% in the last year.
More than a third (35.0%) of all respondents reported experiencing at lfeast one symptom
possibly indicative of lung cancer in the last year (Table 4). The corresponding figure for
upper gastrointestinal cancer symptoms was 29.4%, non-specific cancer symptoms 21.3% and
colorectal cancer symptoms 17.3%. Breast cancer symptoms were less common: 3.6% in
females and 0.3% in males. Among the 5,880 participants who reported experiencing at least
one symptom possibly indicative of lung cancer in the last year, 4,041 (68.7%) had not previ-
ously been diagnosed with asthma, chronic bronchitis/COPD or other chest disorder. Simi-
larly, among the 4,929 participants who reported experiencing at least one symptom possibly
indicative of upper gastrointestinal tract cancer in the last year, 3,009 (61.0%) had never been
diagnosed as having a stomach/digestive disorder.
Table 3. Number of symptoms experienced in the last month and year by the respondents.
All respondents (N = 16778) Respondents without a diagnosis of cancer (n = 15001)
All 25 symptoms All 21 symptoms possibly
indicative of cancer
All 25 symptoms All 21 symptoms possibly
indicative of cancer
n % n % n % n %
Symptoms in last month
0 5142 30.6 9095 54.2 4641 30.9 8224 54.8
1 4282 25.5 3580 21.3 3858 25.7 3199 21.3
2 2918 17.4 1860 11.1 2598 17.3 1649 11.0
3 1774 10.6 994 5.9 1587 10.6 863 5.8
4 973 5.8 544 3.2 860 5.7 468 3.1
5 635 3.8 319 1.9 548 3.7 284 1.9
>5 1054 6.3 386 2.3 909 6.1 314 2.1
Mean (SD) 1.82 (2.09) 1.01 (1.57) 1.79 (2.06) 0.98 (1.53)
Symptoms in last year
0 3357 20.0 6968 41.5 3031 20.2 6319 42.1
1 3503 20.9 3715 22.1 3166 21.1 3334 22.2
2 3114 18.6 2365 14.1 2783 18.6 2093 14.0
3 2225 13.3 1448 8.6 1982 13.2 1284 8.6
4 1484 8.8 893 5.3 1332 8.9 780 5.2
5–7 2190 13.1 1092 6.5 1936 12.9 957 6.4
8–10 649 3.9 250 1.5 569 3.8 199 1.3
>10 256 1.5 47 0.3 202 1.3 35 0.2
Mean (SD) 2.61 (2.55) 1.51 (1.96) 2.58 (2.51) 1.47 (1.92)
SD = Standard Deviation
https://doi.org/10.1371/journal.pone.0228033.t003
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Characteristics of those experiencing symptoms
Compared with their respective referent group, women, those unable to work because of ill-
ness or disability, ex- and current-smokers and those with a history of a specified condition
were significantly more likely to report experiencing at least one symptom possibly indicative
of the four cancers of interest; in both time periods and after adjusting for other factors
(Table 5). On the other hand, those aged 60 to 69 years, those with medium or high social sup-
port and those in a household within an income of at least £15,000 were significantly less likely
Table 4. Proportion of respondents having experienced symptoms possibly indicative of different cancers in the last month and year, and proportion of those with
the symptoms who contacted their GP about it.
In last month In last year:
Had symptom Contacted GP in
last month¥
Had symptom Contacted GP about symptom in last year¥
n /16778 (%, 99% CI) n/S (%, 99% CI) n /16778 (%, 99% CI) n/S (%, 99% CI)
Persistent indigestion/heartburn 1969 (11.7, 11.1–12.3) 330 (16.8, 14.6–19.0) 2769(16.5, 15.8–17.2) 1221 (44.1, 41.7–46.5)
Difficulty swallowing !! 573 (3.4, 3.0–3.8) 103 (18.0, 13.9–22.1) 884 (5.3, 4.9–5.6) 327 (37.0, 32.8–41.2)
Stomach or abdominal pain 1661 (9.9, 9.3–10.5) 427 (25.7, 22.9–28.5) 2734 (16.3, 15.6–17.0) 1322 (48.4, 45.9–50.9)
Persistent vomiting 36 (0.2, 0.1–0.3) 18 (50.0, 28.5–71.5) 95 (0.6, 0.5–0.8) 57 (60.0, 47.1–73.0)
Vomiting up blood !! 3 (0.0, 0.0–0.0) 0 (-) 12 (0.1, 0.0–0.2) 7 (58.3, 21.6–95.0)
At least one upper GI tract cancer symptom 3418 (20.4, 19.6–21.2) 715 (20.9, 19.1–22.7) ^ 4929 (29.4, 28.5–30.3) 2464 (50.0, 48.2–51.8) ^
Chest pain 908 (5.4, 5.0–5.9) 283 (31.2, 27.2–35.2) 1490 (8.9, 8.3–9.5) 842 (56.5, 53.2–59.8)
Hoarseness 775 (4.6, 4.2–5.0) 117 (15.1, 11.8–18.4) 1319 (7.9, 7.4–8.4) 378 (28.7, 25.5–31.9)
Persistent cough 1356 (8.1, 7.6–8.6) 378 (27.9, 24.8–31.0) 2189 (13.0, 12.3–13.7) 1101 (50.3, 47.6–53.1)
Change in ongoing cough 188 (1.1, 0.9–1.3) 62 (33.0, 24.2–41.8) 298 (1.8, 1.5–2.1) 145 (48.7, 41.2–56.2)
Coughing up phlegm 1481(8.8, 8.2–9.4) 288 (19.4, 16.8–22.1) 2241 (13.4, 12.7–14.1) 850 (37.9, 35.3–40.5)
Coughing up blood !! 36 (0.2, 0.1–0.3) 10 (27.8, 8.6–47.0) 91 (0.5, 0.4–0.6) 60 (65.9, 53.1–78.7)
Shortness of breath 1989 (11.9, 11.3–12.5) 562 (28.3, 25.7–30.9) 2647 (15.8, 15.1–16.5) 1419 (53.6, 51.1–56.1)
At least one lung cancer symptom 4194 (25.0, 24.1–25.9) 1024 (24.4, 22.7–26.1) ^ 5880 (35.0, 34.1–36.0) 3131 (53.2, 50.9–55.5) ^
Persistent diarrhoea 499 (3.0, 2.7–3.3) 115 (23.0, 18.2–27.9) 729 (4.3, 3.9–4.7) 343 (47.1, 42.3–51.9)
Persistent constipation 726 (4.3, 3.9–4.7) 129 (17.8, 14.1–21.5) 964 (5.7, 5.2–6.2) 435 (45.1,41.0–49.2)
Change in bowel habits 837 (5.0, 4.6–5.4) 235 (28.1, 24.1–32.1) 1323 (7.9, 7.4–8.4) 641 (48.5, 45.0–52.0)
Blood in stool or rectal bleeding !! 487 (2.9, 2.6–3.2) 94 (19.3, 14.7–23.9) 872 (5.2, 4.8–5.6) 399 (45.8, 41.5–51.2
At least one colorectal cancer symptom 2013 (12.0, 11.4–12.7) 416 (20.7, 18.4–23.0) ^ 2897 (17.3, 16.6–18.1) 1404 (48.5, 45.1–51.9) ^
Lump in breast !! 77 (0.5, 0.4–0.6) 24 (31.2, 17.6–44.8) 175 (1.0, 0.8–1.2) 135 (77.1, 68.9–85.3)
Breast change other than lump 110 (0.7, 0.5–0.9) 42 (38.2, 26.3–50.1) 208 (1.2, 1.0–1.4) 132 (63.5, 54.9–72.1)
At least one breast cancer symptom 178 (1.1, 0.9–1.3) ‡ 63 (35.4, 26.2–44.6) ^ 355 (2.1, 1.8–2.4) ‡‡ 259 (73.0, 66.9–79.1) ^
Loss of appetite 478 (2.8, 2.5–3.1) 100 (20.9, 16.1–25.7) 883 (5.3, 4.9–5.8) 276 (31.3, 27.3–35.3)
Unexplained weight loss !! 158 (0.9, 0.7–1.1) 63 (39.9, 29.9–49.9) 341 (2.0, 1.7–2.3) 189 (55.4, 48.5–62.3)
Tired all the time 2516 (15.0, 4.3–15.7) 570 (22.7, 20.6–24.9) 3078 (18.3, 17.5–19.1) 1300 (42.2, 39.9–44.5)
At least one non-specific cancer symptom 2756 (16.4, 15.7–17.1) 630 (22.9, 20.8–25.0) ^ 3577 (21.3, 20.5–22.1) 1639 (45.8, 42.6–49.0) ^
At least one red flag symptom 1239 (7.4, 6.9–7.9) 278 (22.4, 19.4–25.5) ^ 2131 (12.7, 12.0–13.4) 1085 (50.9, 48.1–53.7) ^
At least one cancer symptom 7683 (45.8, 44.8–46.8) 2038 (26.5, 25.2–27.8) ^ 9810 (58.4, 57.4–59.4) 5836 (59.5, 58.5–60.5) ^
¥ Symptomatic people with information missing about contact with their GP were assumed to have not seen their family doctor
n = number, n/S = number contacting GP/respondents experiencing this symptom, CI = confidence interval
!! = red flag cancer symptom
^ proportion who saw GP for at least one of the symptoms in this group
‡ 159/9033 (1.8, 1.4–2.2) in females
‡‡ 328/9033 (3.6, 3.1–4.1) in females
https://doi.org/10.1371/journal.pone.0228033.t004
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Table 5. Proportion and chance of participants in different subgroups reporting having experienced at least one symptom possibly indicative of cancer in the last
month and last year.
In the last month In the last year
Sub-group† % (99% CI) UOR (99% CI) AOR� (99% CI) % (99% CI) UOR (99% CI) AOR� (99% CI)
Sex (Male)R 44.0 (42.6–45.5) 56.3 (54.9–57.8)
Female 47.3 (46.0–48.7) 1.15 (1.06–1.24) 1.19 (1.08–1.31) 60.3 (59.0–61.6) 1.18 (1.09–1.28) 1.19 (1.08–1.32)
Age (50–59)R 44.6 (43.9–46.3) 60.1 (58.4–61.8)
60–69 43.3 (41.7–44.9) 0.95 (0.86–1.04) 0.84(0.73–0.96) 56.0 (54.4–57.6) 0.85 (0.77–0.93) 0.75 (0.66–0.86)
70–79 47.1 (45.0–49.2) 1.10 (0.99–1.23) 0.91 (0.77–1.09) 57.3 (55.2–59.4) 0.89 (0.80–1.00) 0.74 (0.62–0.88)
80+ 60.9 (57.2–64.6) 1.93 (1.63–2.89) 1.49 (1.16–1.91) 68.3 (64.8–71.8) 1.43 (1.20–1.71) 1.12 (0.87–1.45)
Marital status (Single)R 47.1 (56.0–64.6) 59.8 (56.0–63.6)
Married/living together 43.9 (42.8–45.1) 0.88 (0.75–1.03) 1.07 (0.88–1.30) 56.9 (55.8–58.1) 0.89 (0.75–1.05) 1.05 (0.87–1.28)
No longer married 52.9 (50.6–55.2) 1.26 (1.05–1.51) 1.16 (0.94–1.43) 64.6 (62.4–66.8) 1.23 (1.02–1.48) 1.19 (0.97–1.48)
Social support (Low)R 54.8 (50.6–59.1) 66.4 (62.4–70.4)
Medium 46.7 (45.0–48.4) 0.72 (0.60–0.87) 0.80 (0.65–0.99) 58.8 (57.1–60.5) 0.72 (0.60–0.88) 0.78 (0.63–0.96)
High 44.6 (43.3–45.9) 0.66 (0.55–0.79) 0.75 (0.61–0.92) 57.9 (56.6–59.2) 0.70 (0.58–0.84) 0.76 (0.61–0.94)
Education (No qualifications)R 51.9 (49.1–54.7) 60.7 (57.9–63.5) 0.76 (0.61–0.94)
Secondary school or equivalent 47.6 (45.8–49.4) 0.84 (0.74–0.96) 1.00 (0.84–1.17) 59.0 (57.3–60.7) 0.93 (0.81–1.07)
1.
1.06 (0.90–1.25)
College/vocational courses and other 49.4 (44.4–54.4) 0.90 (0.72–1.14) 0.95 (0.73–1.25) 62.1 (57.2–67.0) 1.06 (0.84–1.35) 1.05 (0.80–1.38)
Professional qualification 44.8 (42.8–46.8) 0.75 (0.66–0.87) 0.97 (0.81–1.15) 58.8 (56.9–20.7) 0.92 (0.80–1.06) 1.09 (0.91–1.30)
Degree or postgraduate qualification 40.9 (38.9–42.9) 0.64 (0.56–0.77) 0.91 (0.76–1.09) 56.0 (54.0–58.0) 0.82 (0.72–0.95) 1.04 (0.87–1.25)
Employment (Working full-time)R 42.3 (40.3–44.4) 57.5 (55.5–59.6)
Working part-time 42.4 (39.2–45.6) 1.00 (0.86–1.17) 0.89 (0.75–1.07) 56.1 (52.9–59.3) 0.95 (0.81–1.10) 0.88 (0.74–1.05)
Self-employed 43.7 (40.1–47.4) 1.06 (0.90–1.26) 1.05 (0.87–1.27) 57.7 (54.1–61.3) 1.01 (0.85–1.20) 1.05 (0.86–1.27)
Retired 46.2 (44.8–47.6) 1.17 (1.06–1.30) 0.87 (0.74–1.02) 57.7 (56.3–59.1) 1.01 (0.91–1.11) 0.90 (0.77–1.05)
Unable to work due to illness/disability 86.5 (82.2–90.8) 8.77 (6.02–12.77) 5.50 (3.57–8.47) 91.3 (87.8–94.8) 7.71 (4.91–12.10) 4.72 (2.87–7.76)
Others not in paid employment 47.5 (42.0–53.0) 1.23 (0.98–1.56) 0.98 (0.75–1.29) 61.6 (56.3–66.9) 1.18 (0.93–1.51) 1.00 (0.76–1.33)
Household income (< £15,000)R 54.7 (52.6–56.9) 64.9 (62.8–67.0)
£15,000–29,999 45.4 (43.5–47.3) 0.69 (0.61–0.77) 0.82 (0.72–0.94) 57.0 (55.1–58.9) 0.72 (0.64–0.81) 0.82 (0.71–0.94)
£30,000–49,999 42.5 (40.4–44.6) 0.61 (0.54–0.69) 0.80 (0.68–0.93) 56.8 (54.7–58.9) 0.71 (0.63–0.81) 0.83 (0.71–0.97)
>£50,000 38.3 (36.1–40.6) 0.51 (0.45–0.58) 0.68 (0.57–0.81) 54.6 (52.3–56.9) 0.65 (0.57–0.74) 0.74 (0.62–0.88)
Smoking status (Never smoked)R 41.6 (40.3–43.0) 55.0 (53.6–56.4)
Ex-smoker 50.0 (48.4–51.7) 1.41 (1.29–1.53) 1.29 (1.16–1.42) 61.8 (60.2–63.4) 1.32 (1.21–1.45) 1.23 (1.12–1.36)
Current smoker 54.2 (50.9–57.6) 1.67 (1.44–1.93 1.54 (1.31–1.83) 65.5 (62.3–68.7) 1.55 (1.33–1.80) 1.37 (1.15–1.63)
Rural Urban (Scotland large urban) R 45.9 (43.6–48.2) 60.9 (58.7–63.1)
Scotland other urban areas 45.5 (42.1–48.9) 0.98 (0.83–1.16) 0.99 (0.82–1.20) 58.6 (55.3–62.0) 0.91 (0.77–1.07) 0.91 (0.75–1.10)
Scotland accessible small towns 45.6 (40.5–50.7) 0.99 (0.79–1.24) 0.92 (0.71–1.19) 57.8 (52.8–62.8) 0.88 (0.70–1.10) 0.84 (0.65–1.08)
Scotland remote small towns 45.4 (42-2-48.6) 0.98 (0.84–1.15) 1.03 (0.86–1.24) 57.8 (54.6–61.0) 0.88 (0.75–1.03) 0.94 (0.78–1.13)
Scotland accessible rural 43.6 (39.5–47.7) 0.91 (0.75–1.10) 0.98 (0.79–1.22) 55.6 (51.5–59.7) 0.80 (0.66–0.97) 0.85 (0.68–1.06)
Scotland remote rural 44.5 (40.5–48.5) 0.95 (0.78–1.14) 0.96 (0.77–1.19) 57.4 (53.4–61.4) 0.87 (0.72–1.04) 0.90 (0.73–1.12)
England urban with city and town 50.5 (47.9–53.2) 1.20 (1.04–1.38) 1.09 (0.92–1.30) 61.9 (59.3–64.5) 1.04 (0.90–1.20) 0.96 (0.81–1.14)
England urban with significant rural 43.7 (41.4–46.0) 0.92 (0.81–1.04) 0.94 (0.81–1.09) 56.5 (54.2–58.8) 0.83 (0.73–0.95) 0.87 (0.74–1.01)
England largely rural 45.9 (43.2–48.6) 1.00 (0.87–1.15) 1.00 (0.85–1.18) 56.6 (53.9–59.3) 0.83 (0.72–0.96) 0.85(0.72–1.00)
Diagnosis of specified condition (No)R 27.0 (25.1–28.9) 40.8 (38.7–42.9)
Yes 50.8 (49.7–51.9) 2.80 (2.51–3.12) 2.65 (2.35–3.00) 63.2 (62.1–64.3) 2.50 (2.26–2.76) 2.48 (2.21–2.78)
CI = confidence interval, UOR = unadjusted odds ratio, AOR = adjusted odds ratio
† Number in each subgroup as per Table 1.
�adjusted odds ratio: adjusted for gender, age, marital status, social support, education, employment, household income, smoking, rurality, ever diagnosis of specified
condition, except when the variable itself is being examined.
R = Referent group for odds ratios
https://doi.org/10.1371/journal.pone.0228033.t005
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to report at least one symptom possibly indicative of cancer irrespective of what time frame
was used. Marital status, education and rurality were not significant variables in the adjusted
model. There were generally few statistically significant adjusted differences between sub-
groups in the chances of experiencing symptoms possibly indicative of the different cancers in
the last year (S2 Table). Where differences did emerge, the pattern of associations was broadly
consistent with that of experiencing any symptom possibly indicative of cancer, i.e. higher
reporting among females, those unable to work because of illness, smokers and individuals
with a history of one of the specified medical conditions; and less among those aged 60 to 79
years, those with greater social support and those with higher household incomes.
Proportion contacting the GP
Overall, 26.5% of respondents experiencing at least one symptom possibly indicative of the
four cancers in the last month contacted their GP about at least one symptom, and 59.5% in
the previous year (Table 4). The corresponding proportions were smaller among participants
experiencing at least one red flag symptom; 22.4% and 50.9% respectively. Contact with the
GP varied greatly for individual (including red flag) symptoms; between 15.1% (hoarseness)
and 50.0% (persistent vomiting) for symptoms experienced in the last month and between
28.7% (hoarseness) and 77.1% (lump in breast) in the last year.
Characteristics of those contacting the GP
Table 6 shows the association between different characteristics of the respondents and the like-
lihood of contacting the GP if a symptom possibly indicative of cancer was experienced in the
last month or last year. In the adjusted model, compared with their respective referent group,
symptomatic women, those aged 80+ years, those unable to work due to illness or disability,
ex-smokers and those with a history of a specified condition were more likely to contact their
GP about at least one symptom; and people with the highest level of household income less
likely to do so. The pattern of associations was the same regardless of the time frame (last
month or last year) considered for experiencing symptoms.
Discussion
Main findings
Symptoms possibly indicative of cancer were common in the adults surveyed in our study,
with nearly half experiencing at least one such symptom in the last month and nearly three-
fifths in the last year. Many people experienced multiple symptoms. The prevalence of individ-
ual symptoms varied widely, with red flag symptoms at the lower end of the range. The preva-
lence of symptoms varied within different population subgroups. More than three quarters of
respondents experiencing at least one red flag symptom in the last month did not reported it
to their GP, and nearly half of those experiencing such symptoms in the last year. There were
important variations in the level of GP help-seeking by symptom type and the characteristics
of person experiencing them.
Strengths and limitations
The USEFUL study is the largest investigation so far in the UK of the prevalence and GP help-
seeking responses to symptoms possibly indicative of cancer in a community setting. Its large
size meant that we had good precision for common symptoms. The questionnaire underwent
detailed refinement during both the development phase when experts and lay members
reviewed early drafts and the pilot phase which resulted in some changes to make the
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Table 6. Proportion and chance of participants in different subgroups experiencing at least one symptom possibly indicative of the four cancers and seeing their
GP for at least one such symptom in the last month and last year.
In the last month In the last year
Sub-group† % (99% CI) UOR (99% CI) AOR� (99% CI) % (99% CI) UOR (99% CI) AOR� (99% CI)
Sex (Male)R 25.2 (23.9–26.5) 56.2 (54.8–57.7)
Female 27.2 (26.0–28.4) 1.21 (1.07–1.36) 1.17 (1.01–1.37) 62.2 (60.9–63.5) 1.30 (1.19–1.41) 1.29 (1.17–1.43)
Age (50–59)R 24.9 (23.4–26.4) 55.4 (53.7–57.1)
60–69 26.2 (24.8–27.6) 1.03 (0.88–1.12) 0.91 (0.74–1.12 59.0 (57.4–60.6) 0.99 (0.89–1.09) 0.90 (0.78–1.03)
70–79 27.6 (25.7–29.5) 1.20 (1.01–1.41) 1.12 (0.78–1.32 63.8 (61.8–65.8) 1.15 (1.03–1.29) 1.00 (0.84–1.20
80+ 31.0 (27.534.5)- 1.86 (1.49–2.32) 1.54 (1.10–2.16) 67.0 (63.4–70.6) 1.69 (1.42–2.00) 1.48 (1.15–1.89)
Marital status (Single)R 26.1 (22.7–29.5 57.1 (53.3–60.9)
Married/living together 25.3 (24.3–26.3) 0.89 (0.70–1.14) 1.08 (0.81–1.44) 58.8 (57.7–59.9) 0.97 (0.82–1.15) 1.06 (0.87–1.29)
No longer married 30.5 (28.4–32.6) 1.38 (1.05–1.79) 1.24 (0.92–1.69) 62.9 (60.7–65.1) 1.32 (1.10–1.60) 1.15 (0.92–1.42)
Social support (Low)R 23.2 (19.6–26.8) 57.8 (53.6–62.0)
Medium 25.7 (24.2–27.2) 0.93 (0.71–1.23) 1.08 (0.78–1.48) 58.3 (56.6–60.0) 0.84 (0.69–1.02) 0.90 (0.73–1.12)
High 27.3 (26.1–28.5) 0.95 (0.73–1.24) 1.12 (0.82–1.53) 59.9 (58.6–61.2) 0.85 (0.71–1.03) 0.93 (0.75–1.15)
Education (No qualifications)R 28.3 (25.7–30.9) 64.5 (61.8–67.2)
Secondary school or equivalent 28.1 (26.5–29.7) 0.90 (0.74–1.09)
1.1
0.97 (0.77–1.22 62.0 (60.3–63.7) 0.90 (0.78–1.03) 1.02 (0.86–1.20)
College/vocational courses and other 32.2 (27.5–36.9) 1.10 (0.80–1.51) 1.13 (0.78–1.63) 61.2 (56.3–66.1) 0.96 (0.75–1.21) 1.00 (0.75–1.31)
Professional qualification 25.8 (24.0–27.5) 0.76 (0.62–0.93) 0.94 (0.73–1.20) 58.3 (56.4–60.3) 0.81 (0.70–0.94) 0.97 (0.81–1.16)
Degree or postgraduate qualification 22.4 (20.7–24.1) 0.58 (0.47–0.72) 0.82 (0.63–1.07) 54.4 (52.4–56.4) 0.68 (0.59–0.79) 0.88 (0.73–1.07)
Employment (Working full-time)R 22.5 (20.8–24.2) 53.5 (51.4–55.6)
Working part-time 27.0 (24.1–29.9) 1.23 (0.96–1.58) 1.04 (0.79–1.38) 58.5 (55.3–61.7) 1.10 (0.94–1.30) 0.98 (0.81–1.18)
Self-employed 22.2 (19.1–25.3) 1.02 (0.77–1.36) 0.91 (0.66–1.25) 54.1 (50.4–57.8) 1.02 (0.85–1.23) 0.98 (0.80–1.21)
Retired 27.0 (25.8–28.2) 1.36 (1.15–1.60) 0.94 (0.73–1.20) 61.4 (60.1–62.7) 1.24 (1.11–1.38) 0.93 (0.79–1.10)
Unable to work due to illness/disability 43.4 (37.2–49.6) 5.73 (4.27–7.70) 3.50 (2.47–4.95) 78.8 (73.7–83.9) 5.75 (4.29–7.71) 3.92 (2.81–5.49)
Others not in paid employment 28.2 (23.3–33.1) 1.47 (1.04–2.09) 1.27 (0.86–1.90) 63.5 (58.2–68.8) 1.45 (1.14–1.84) 1.24 (0.93–1.64)
Household income (< £15,000)R 31.0 (29.0–33.0) 64.5 (62.4–66.6)
£15,000–29,999 26.5 (24.8–28.2) 0.67 (0.57–0.79) 0.87 (0.71–1.05) 60.5 (58.6–62.4) 0.73 (0.65–0.83) 0.91 (0.79–1.04)
£30,000–49,999 24.0 (22.2–25.8) 0.55 (0.46–0.67) 0.79 (0.63–1.00) 57.8 (55.7–59.9) 0.68 (0.60–0.77) 0.93 (0.79–1.09)
>£50,000 19.9 (18.1–21.8) 0.40 (0.33–0.50) 0.62 (0.47–0.82) 52.0 (49.7–54.3) 0.55 (0.48–0.63) 0.79 (0.66–0.95)
Smoking status (Never smoked)R 25.4 (24.2–26.6) 58.5 (57.2–59.9)
Ex-smoker 27.9 (26.4–29.4) 1.37 (1.21–1.56) 1.23 (1.06–1.43) 60.9 (50.3–62.5) 1.27 (1.16–1.39) 1.16 (1.05–1.29)
Current smoker 26.6 23.6–29.6) 1.43 (1.16–1.76) 1.21 (0.95–1.54) 57.4 (54.1–60.7) 1.27 (1.09–1.47) 1.13 (0.95–1.35)
Rural Urban (Scotland large urban)R 28.3 (26.3–30.3) 58.2 (56.0–60.4)
Scotland other urban areas 23.6 (20.7–26.5) 0.81 (0.62–1.04) 0.82 (0.61–1.10) 61.0 (57.7–64.3) 1.01 (0.85–1.20) 0.98 (0.81–1.20)
Scotland accessible small towns 30.5 (25.8–35.2) 1.08 (0.78–1.50) 0.86 (0.58–1.26) 63.0 (58.1–67.9) 1.04 (0.83–1.31) 0.92 (0.71–1.20)
Scotland remote small towns 25.7 (22.9–28.5) 0.89 (0.69–1.13) 0.86 (0.65–1.13) 58.9 (55.7–62.1) 0.94 (0.79–1.11) 0.92 (0.76–1.12)
Scotland accessible rural 26.6 (22.9–30.3) 0.88 (0.65–1.18) 0.92 (0.66–1.28) 58.3 (54.2–62.4) 0.87 (0.71–1.07) 0.89 (0.71–1.13)
Scotland remote rural 28.8 (25.1–32.5) 0.99 (0.75–1.30) 1.01 (0.74–1.39) 58.1 (54.1–62.1) 0.91 (0.75–1.11) 0.92 (0.73–1.15)
England urban with city and town 28.5 (26.1–30.9) 1.12 (0.92–1.38) 0.95 (0.75–1.21) 61.7 (59.1–64.3) 1.13 (0.97–1.30) 1.00 (0.84–1.19)
England urban with significant rural 24.6 (22.6–26.6) 0.81 (0.66–0.99) 0.79 (0.63–1.00) 59.7 (57.5–61.9) 0.92 (0.81–1.06) 0.89 (0.76–1.04)
England largely rural 24.7 (22.4–27.0) 0.86 (0.69–1.06) 0.82 (0.64–1.05) 58.2 (55.6–60.9) 0.89 (0.77–1.04) 0.85 (0.72–1.01)
Diagnosis of specified condition (No)R 17.0 (15.4–18.6) 43.0 (40.9–45.2)
Yes 27.9 (26.9–28.9) 3.44 (2.77–4.27) 2.97 (2.32–3.79) 62.3 (61.2–63.4) 3.05 (2.70–3.45) 2.80 (2.44–3.21)
CI = confidence interval, UOR = unadjusted odds ratio, AOR = adjusted odds ratio
† Number in each subgroup as per Table 1.
�adjusted odds ratio: adjusted for gender, age, marital status, social support, education, employment, household income, smoking, rurality, ever diagnosis of specified
condition, except when the variable itself is being examined.
R = Referent group for odds ratios
https://doi.org/10.1371/journal.pone.0228033.t006
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questionnaire easier to follow. A key consideration when discussing early drafts was whether
our symptom descriptors accorded with lay understanding. The symptom components of the
questionnaire were based on a questionnaire used in a previous study, which had been found
to collect appropriate data [17, 18]. Questions about the specific concepts of illness perceptions
and cancer awareness were taken from validated questionnaires (Brief Illness Perception Ques-
tionnaire [29] and Cancer Awareness Measure [16]). We looked at symptom experience over
the past month (the main focus) and past year. The patterns of associations were the same
regardless of the time frame used. It was useful to include both timeframes to ensure our find-
ings were comparable to previous research in other countries [13].
Masking symptoms were included in the questionnaire, and the explicit mention of cancer
avoided, to limit potential anxiety and minimise the biasing of responses. Even so, some recipi-
ents may have become aware of our interest in cancer, having seen a description of the study
on a publically accessible website, such as that of Cancer Research UK which stated that the
study was looking at cancer. Three recipients of the invitation to participate contacted us to
clarify the study’s purpose. Although some participants reported a history of cancer when
completing the questionnaire. We have no information about cancer screening within the
study sample. We found that the inclusion of people with a history of cancer did not materially
affect our prevalence results. Some of the reported symptoms are likely to have arisen from
other chronic conditions. Nevertheless, most cancer awareness campaigns are targeted at the
total population regardless of previous or current medical history, so understanding the preva-
lence and pattern of cancer-related symptoms, and associated help-seeking behaviour, in the
total population is essential. Previous studies investigating GP help-seeking have often focused
on individuals with cancer, retrospectively examining their symptom experiences prior to
diagnosis [5–7, 30–34]. Such studies are limited by variable patient recall [35] and possible
changes in symptom interpretation post diagnosis [36]. Our study participants were of an age
(50+ years) when the incidence of cancer rises sharply, and when many cancer initiatives, such
as screening, cancer awareness campaigns or clinical guidance of prompt investigation for par-
ticular symptoms begins [37, 38]. Thus, our results may match reality more closely than those
of studies involving a different age group or asking about anticipated delays for hypothetical
scenarios [12, 39, 40].
We were able to consider a large number of factors in the analyses that may be related to
the reporting of symptoms possibly indicative of cancer. Some consistent associations were
observed, both overall and for symptoms associated with different types of cancer. The cross-
sectional nature of the study, however, means that we are unable to determine whether the
observed associations were causal. Furthermore, as with any observational study, residual con-
founding from factors (such as lifestyle) not included in the model may have occurred. This
said, our observations should be informative for the targeting of future cancer symptom
awareness campaigns and interventions throughout the UK.
We did not have information about how many practices approached by the research net-
works declined to participate, or about the characteristics of participating practices compared
to non-participating practices. In addition, we have no information about the number of, and
reasons for, exclusions made by the participating practices when screening the lists of potential
invitees. We do not know therefore how generalizable our results are to the wider UK
population.
The sampling of patients registered with a GP is a method routinely used in the UK for
sampling the general population since most people are registered with a GP so that they can
obtain healthcare. Non-registered individuals who were excluded from our study may have a
different experience of symptoms possibly indicative of cancer than participants in our study,
and probably different patterns of response to these symptoms. A key consideration when
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interpreting our findings is the low response rate; a common problem with recent epidemio-
logical research [4, 15, 17, 18, 41, 42]. We tried to mitigate against a low response rate by using
a number of recommended approaches [43], including inviting participation using personal-
ised letters on general practice-headed notepaper, offering both on-line and paper question-
naires and sending two reminders. We did not have ethics approval or resources to increase
participation further, such as by using a telemarketing company to approach non-responders
or holding a lottery for respondents [14]. The primary concern with low response rates is its
potential to introduce bias. There was evidence of differential response by gender, age, rurality
and deprivation. It is difficult to assess the overall impact of this on our findings, although
there may have been some underestimation of symptom prevalence since those on lower
incomes (less likely to respond) appeared more likely to report symptoms possible indicative
of cancer.
As with all other investigations of symptoms, our study was based on self-reported informa-
tion. Deliberately, we did not define or explain symptom descriptors such as ‘persistent’ or
‘unexplained’. It is likely that these descriptors have different meanings for different people. In
a separate exercise we have conducted qualitative interviews with a number of participants to
examine their perceptions of the term ‘persistence’. These findings will be published in a sepa-
rate paper. Importantly, our study shows how many people perceived themselves to have such
symptoms, and how they responded. We have found that participant self-report of help-seek-
ing for symptoms possibly indicative of cancer is reasonably accurate [44]. Individuals may
have differed in their understanding of what was meant by the symptoms listed, although our
development work involved members of the general public in an attempt to mitigate against
this. Furthermore, many people had a previous diagnosis of a number of medical conditions,
reflecting the age profile of our sample. We do not know how many people had active symp-
tomatic disease, particularly chronic disease, which may affect awareness and response to dif-
ferent symptoms. Where we were able to assess this (i.e. for symptoms possibly indicative of
lung or upper gastrointestinal cancer) we found that most symptoms occurred in participants
without a previous relevant diagnosis; suggesting that our findings were not simply due to a
high proportion of participants with historic diagnoses which had been symptomatic for some
time. Although subjective, symptoms are powerful drivers of healthcare service use, so under-
standing how people experience and react to them remains crucial.
Space constraints prevent us from presenting in-depth patterns of, and different influences
on, help-seeking responses to experienced symptoms. Subsequent papers will provide this
information. Nevertheless, the top-level results presented here show important variations
within the general population in GP help-seeking behaviour, highlighting the need for research
in this area.
Other studies
Few studies have assessed a range of symptoms possibly indicative of cancer from a commu-
nity perspective. Furthermore, comparison between studies can be difficult because of differ-
ences in the range of symptoms assessed, descriptors used and the age of participants. For
example, only six of the 44 symptoms included in the Danish Symptom Cohort study [14]
used the same wording as our study; with another four using broadly similar wording
(Table 7). The proportion of people in the Danish study experiencing these symptoms in the
preceding month was higher (albeit sometimes only marginally) for eight of the ten symptoms,
than in our study. Some of the differences may be attributable to the inclusion of younger par-
ticipants in the Danish study; we found in a previous UK study [18] a higher prevalence of
symptoms among younger people. The Danish study also found that more people contacted
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their GP for seven of the ten symptoms. Indeed the level of contact with a GP for at least one
symptom (37%) was high in the Danish study. Another study conducted in one region of Den-
mark (Funen), of adults aged 20+ years, reported a higher proportion of people experiencing
having a lump in the breast during the preceding 12 months (3.3%), a similar proportion with
blood in stool (5.7%) and a lower proportion with cough longer than six weeks (6.5%), than in
our study. These differences highlight the need for country specific information about the
prevalence of symptoms experienced in the community, and associated help-seeking behav-
iour. Our prevalence and contact with GP findings, obtained from an older population
responding to questions focused in symptoms possibly indicative of cancer and which
included terms such as persistent, are most pertinent to planners of UK-based cancer aware-
ness campaigns.
A postal questionnaire-based study 3,756 individuals aged 50+ years without cancer and
recruited from seven general practices in London, South East and North West England asked
about the occurrence of 10 cancer red flag symptoms in the last three months. [15]. Like our
study, the prevalence of symptoms was high: 46% of participants reported at least one red flag
symptom, with individual symptom prevalence ranging between 2.9% (unexplained bleeding)
and 16.9% (cough or hoarseness). Similar to our study, there was a wide variation in the propor-
tion of symptoms resulting in GP help-seeking: overall 67% of all symptoms were presented,
and individually between 53.5% (cough or hoarseness) and 72.0% (unexplained lump) of
symptoms.
The Funen study also looked at factors associated with the reporting of at least one cancer
red flag symptom [45]. It found that women, individuals not in the workforce (including
because of disability), and those with a cancer diagnosis were more likely to report at least one
red flag symptom; with older participants and those living with a partner less likely. Apart
from age, these associations are consistent with our findings.
Implications
Cancer awareness campaigns can increase the proportion of symptomatic individuals seeking
help. For example, a national eight week campaign in England in 2012, focused on persistent
or prolonged cough as a prompt to seek help to avoid lung cancer [46]. It resulted in a 3%
increase in the public’s awareness of the potential importance of this symptom (from 12% to
Table 7. Comparison of the proportion of people reporting different symptoms and proportion seeking GP help in the last month, between our study and the Dan-
ish Symptom Cohort [14].
Our study Danish Study
Had symptom Contacted GP Had symptom Contacted GP
Same wording: % % % %
Difficulty swallowing 3.4 18.0 3.5 34.9
Hoarseness 4.6 15.1 7.7 18.7
Coughing up blood 0.2 27.8 0.1 47.5
Shortness of breath 11.9 28.3 8.0 49.7
Blood in stool or rectal bleeding 2.9 19.3 4.6 33.7
Loss of appetite 2.8 20.9 6.3 19.4
Slightly different wording- our study / Danish study wording:
Stomach or abdominal pain / abdominal pain 9.9 25.7 19.6 27.8
Persistent vomiting / repeated vomiting 0.2 50.0 1.3 33.6
Vomiting up blood / blood in vomit 0.0 0 0.1 37.0
Unexplained weight loss / weight loss 0.9 39.9 3.0 25.1
https://doi.org/10.1371/journal.pone.0228033.t007
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15%), and led to a 67% increase during the campaign in patients of all ages visiting their GP
with a cough- equivalent to six extra consultations per practice per week.
Our results highlight the potential implications of such campaigns for healthcare services,
particularly general practice. In our study, 13% of respondents had a persistent cough in the
previous year, half of whom saw their GP. If those not currently seeing their GP responded
positively to a cancer awareness campaign, 6.5% (1 in 15) of all adults in the UK aged 50
+ might contact their GP for help. Better understanding of how and why people with particular
characteristics respond to symptoms experienced, should enable the tailoring of messages
within cancer awareness campaigns for greater effectiveness.
Conclusion
Symptoms possibly indicative of cancer are common among adults aged 50+ years in the UK,
although they are not evenly distributed. Help- seeking responses to different symptoms also
vary. Our results suggest important opportunities to provide more nuanced messaging and
targeting of symptom-based cancer awareness campaigns.
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